Abstract: By comparison, virus variants recovered from passaging against oseltamivir carboxylate (passage 14) harbored an
E119V mutation and displayed a 6,000-fold-lower susceptibility to oseltamivir carboxylate and a 175-fold-lower susceptibility to zanamivir than did wild-type virus.